知镜 Cognispect · 医学文献与研究工作台

Use of ambrisentan in the management of refractory pulmonary arterial hypertension following occlusion of a bidirectionally shunting patent ductus arteriosus in a dog.

Nemanic TS, Fabella A.
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology · 2026-05-14 · PMID 42241925

文献摘要

A nine-year-old male intact Pomeranian, previously diagnosed with a patent ductus arteriosus (PDA), presented with a two-day history of anorexia and lethargy. Echocardiography confirmed a bidirectional shunting PDA and pulmonary arterial hypertension (PAH). The patient underwent transcatheter occlusion of the PDA; however, there was subsequent development of right heart failure secondary to persistent PAH postoperatively. Combination medical therapy using ambrisentan, sildenafil, pimobendan and amlodipine resulted in resolution of right-sided congestive heart failure and oxygen dependency. Follow-up echocardiography and thoracic radiographs revealed gradual cardiac reverse remodelling and ultimately a structurally normal heart. At the last follow-up, the patient remained stable without complications associated with ductal occlusion. This case highlights the success of bidirectional ductal occlusion with postoperative use of ambrisentan for management of refractory PAH.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。